Novartis | Crediti Commerciali



Trade Debtors Cambiamento Data
AbbVie USD 10.92B 553M 2024-12
Amgen USD 8.13B 1.35B 2025-03
AstraZeneca USD 14.82B 16M 2025-03
Bausch Health Companies USD 2.07B 68M 2025-03
Biogen USD 2B 127.7M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Canopy Growth CAD 49.06M 7.2M 2024-12
Corcept Therapeutics USD 53.98M 5.74M 2024-12
Drreddys Laboratories INR 111.49B 8.65B 2024-12
Eli Lilly USD 14B 727.8M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
Glaxosmithkline GBP 7.32B 542M 2024-12
Indivior 272M 16M 2025-03
J&J USD 16.02B 1.18B 2025-03
Merck USD 11.12B 1.06B 2024-12
Novartis USD 9B 854M 2024-12
Novartis USD 7.56B 594M 2024-12
Pacira USD 113.3M 12.65M 2024-12
Perrigo USD 686.2M 99.7M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Prestige Brands USD 167.27M 3.73M 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
Sanofi 10.63B 1.82B 2024-12
Supernus Pharmaceuticals USD 142.08M 3.33M 2024-12
Zoetis USD 1.32B 95M 2024-12



Novartis Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.